<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <title>Page Title</title>
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <link
      href="https://fonts.googleapis.com/css?family=Montserrat:400,600,700,800,900&display=swap"
      rel="stylesheet"
    />
    <link rel="stylesheet" type="text/css" media="screen" href="css/main.css" />
    <script src="main.js"></script>
  </head>
  <body>
    <header class="header">
      <div class="header__inner-top">
        <div class="header__page-links">
          <a class="text-uppercase" href=""
            >getting started on eversense cgm just got easier</a
          >
          <span>|</span>
          <a class="text-uppercase" href="">eversense bridge program</a>
          <span>></span>
        </div>
        <div class="header__option-dropdown"></div>
      </div>
      <div class="hyperpage">
        <a class="img-logo-link" href="">
          <img src="img/Eversense_logo_white-2x.png" alt="" />
        </a>
        <a class="text-capitalize" href="">what is eversense?</a>
        <a class="text-capitalize" href="">member value</a>
        <a class="text-capitalize" href="">evidence</a>
        <a class="text-capitalize" href="">resource library</a>
        <a class="text-capitalize" href="">reimbursement & processing</a>
      </div>
      <div class="main-headesc">
        <h1 class="text-uppercase">evidence</h1>
        <p>
          The advanced sensor technology and under-the-skin sensor help patients
          reach unprecedented levels of wear time, leading to improved clinical
          outcomes.
        </p>
      </div>
      <div class="hover__links">
        <a class="text-uppercase" href="">real-world adherence</a>
        <a class="text-uppercase" href="">importance of time in range</a>
        <a class="text-uppercase" href="">product performance</a>
        <a class="text-uppercase" href="">clinical trials</a>
      </div>
    </header>

    <div class="advantage">
      <div class="advantage-text">
        <div class="dotted"></div>
        <h2>
          STRONG ACCURACY AND OUTCOMES ACROSS ALL MAJOR INDICATORS
        </h2>
        <div class="dotted"></div>
      </div>
      <div class="advantage-image">
        <img src="img/Eversense_CGM_MOA_Scene_05_Styleframe_v01.png" alt="" />
      </div>
    </div>

    <div class="specs">
      <div class="spec-internal-out">
        <div class="spec-internal-in">
          <div>
            <img src="img/MARD.png" alt="" />
          </div>
          <div>
            <h4 class="spec-text">
              A demonstrated 8.5% Mean Absolute Relative Difference (MARD)¹
            </h4>
          </div>
        </div>
        <div class="spec-internal-in">
          <div>
            <img src="img/Adherence.png" alt="" />
          </div>
          <div>
            <h4 class="spec-text">Sensor adherence of +23hrs per day⁴,⁵</h4>
          </div>
        </div>
      </div>
      <div class="spec-internal-out">
        <div class="spec-internal-in">
          <div>
            <img src="img/technology.png" alt="" />
          </div>
          <div>
            <h4 class="spec-text">
              Fluorescence-based technology unaffected by ascorbic acid and
              acetaminophen²
            </h4>
          </div>
        </div>
        <div class="spec-internal-in">
          <div>
            <img src="img/A1c.png" alt="" />
          </div>
          <div>
            <h4 class="spec-text">
              A clinically meaningful A1C reduction across major studies⁶,⁷,⁸
            </h4>
          </div>
        </div>
      </div>
      <div class="spec-internal-out">
        <div class="spec-internal-in">
          <div>
            <img src="img/accuracy.png" alt="" />
          </div>
          <div>
            <h4 class="spec-text">
              Superior accuracy in the 40-60 mg/dL hypoglycemic range (86.5%
              within 15/15 YSI)³
            </h4>
          </div>
        </div>
        <div class="spec-internal-in">
          <div>
            <img src="img/time-in-range.png" alt="" />
          </div>
          <div>
            <h4 class="spec-text">
              Exceptional 59-69% real-world time in target
            </h4>
          </div>
        </div>
      </div>
    </div>

    <div class="more-info">
      <div class="rec-pattern">
        <img src="img/Rectangle_2.png" alt="" />
      </div>
      <div class="left-bk"></div>
      <div class="more-info-desc">
        <p class="more-info-text">
          For more information on Eversense’s safety and performance, download
          our Performance and Outcomes Data Sheet.
        </p>
      </div>
      <div class="btn-group">
        <div class="btn">PRODUCT SHEET</div>
        <div class="btn">SEE ADDITIONAL PRODUCT DETAILS</div>
      </div>
      <div class="right-bk"></div>
      <div class="rec-pattern pattern-right">
        <img src="img/Rectangle_2.png" alt="" />
      </div>
    </div>

    <div class="new-trials">
      <a href="">
        <span>NEXT:</span>
        <span>Clinical Trials</span>
      </a>
    </div>

    <div class="bibliography">
      <ol>
        <li>
          Christiansen MP. PRECISE II. Diabetes Technology & Therapeutics.
          2018;20(3):197-206.
        </li>
        <li>
          Sensor Chemical Interference Screen Summary Report. Senseonics
          internal reporting, USA, July 2015.
        </li>
        <li>Eversense FDA Summary of Safety and Effectiveness Data (SSED)</li>
        <li>Data on file. Senseonics 2019.</li>
        <li>PRECISE Supplement. Data on file. Senseonics 2018.</li>
        <li>Lind M, Diabetes Metab Syndr. 2008;2(4) 282-293.</li>
        <li>
          Christiansen MP. PRECISE II. Diabetes Technology & Therapeutics.
          2018;20(3):197-206.
        </li>
        <li>Kropff, J. PRECISE study. Diabetes Care, 40(1), 63-68.</li>
      </ol>
    </div>

    <footer class="footer">
      <div class="footer__internal--support">
        <div class="support-link text-uppercase">
          need more information or support?
        </div>
        <div class="support-sublinks">
          <span>844-SENSE4U (736-7348)</span>
          <span>|</span>
          <span class="text-uppercase">chat with us</span>
          <span>|</span>
          <span class="text-uppercase">email us</span>
          <span>|</span>
          <span class="text-uppercase">browse our resources</span>
        </div>
      </div>
      <hr />
      <div class="footer__nav--links">
        <div>
          <h4 class="text-uppercase footer__nav-head">who we are</h4>
          <p class="footer__nav-desc">
            Senseonics, Inc. is a medical device startup company in Germantown,
            Maryland, USA (near Washington, DC) developing transformative
            glucose monitoring products that are intended to enable people with
            diabetes to confidently live their lives with ease.
          </p>
          <span class="text-uppercase learn-btn">learn more</span>
        </div>
        <div>
          <h4 class="text-uppercase footer__nav-head website-link">
            eversense disbetes website
          </h4>
        </div>
        <div class="contact-links">
          <a class="text-uppercase" href="">what is eversense?</a>
          <a class="text-uppercase" href="">member value</a>
          <a class="text-uppercase" href="">evidence</a>
          <a class="text-uppercase" href="">resource library</a>
          <a class="text-uppercase" href="">reimbursement & processing</a>
          <a class="text-uppercase" href="">contact us</a>
        </div>
      </div>
      <hr />
      <div class="disclaimer">
        <p class="text-uppercase disclaimer-head">disclaimer</p>
        <p class="disclaimer-desc">
          The Eversense® Continuous Glucose Monitoring (CGM) System is indicated
          for continually measuring glucose levels in persons age 18 and older
          with diabetes for up to 90 days. It is intended to complement, not
          replace, fingerstick blood glucose monitoring. The sensor insertion
          and removal is performed by a physician. The Eversense CGM System is a
          prescription device; patients should talk to their doctor to learn
          more. For important safety information, see
          <a href="#">https://eversensediabetes.com/safety-info/.</a>
        </p>
        <p class="disclaimer-desc">MKT-5143-01-001</p>
      </div>
      <hr />
      <div class="misc">
        <a href="" class="misc-links">2019</a>
        <a href="" class="misc-links">EULA</a>
        <a href="" class="misc-links">Privacy Policy</a>
        <a href="" class="misc-links">Legal</a>
        <a href="" class="misc-links">Safety</a>
        <a href="" class="misc-links">Contact Us</a>
        <a href="" class="misc-links">Site Map</a>
      </div>
    </footer>
  </body>
</html>
